Brian L. Samuels - Concepedia

Author

Brian L. Samuels

Also Known As

Albert L. Rhoton, B L Samuels, B Samuels, B. L. SAMUELS, B. L. Samuels, B. Samuels, B.L. Samuels, BRIAN L. SAMUELS, Barry Samuels, Brian L Samuels

Publications

4.5K

Citations

H-Index

Concepts

All Affiliations

University of Chicago Advocate Lutheran General Hospital The University of Texas MD Anderson Cancer Center Fox Chase Cancer Center Massachusetts General Hospital

About

Brian L. Samuels is an author at University of Chicago specializing in oncology, medicine, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	25	1.3K
2	Health Sciences	4	4	289
3	Cell Biology	3	3	73
4	Gastroenterology	2	2	101
5	Biochemistry	1	1	71

Brian L. Samuels

Publications

3.9K

Citations

H-Index

Page 1

	Year	Citations
Randomized Phase II Study of Gemcitabine and Docetaxel Compared With Gemcitabine Alone in Patients With Metastatic Soft Tissue Sarcomas: Results of Sarcoma Alliance for Research Through Collaboration Study 002 Robert G. Maki, J. Kyle Wathen, Shreyaskumar Patel, Journal of Clinical Oncology	2007	719
Efficacy and Safety of Trabectedin in Patients With Advanced or Metastatic Liposarcoma or Leiomyosarcoma After Failure of Prior Anthracyclines and Ifosfamide: Results of a Randomized Phase II Study of Two Different Schedules George D. Demetri, Sant P. Chawla, Margaret von Mehren, Journal of Clinical Oncology	2009	524
Multicenter Phase II Trial of ABI-007, an Albumin-Bound Paclitaxel, in Women With Metastatic Breast Cancer Nuhad K. Ibrahim, Brian L. Samuels, Ray D. Page, Journal of Clinical Oncology	2005	270
Efficacy of Imatinib in Aggressive Fibromatosis: Results of a Phase II Multicenter Sarcoma Alliance for Research through Collaboration (SARC) Trial Rashmi Chugh, J. Kyle Wathen, Shreyaskumar Patel, Clinical Cancer Research	2010	236
Phase II Multicenter Trial of Imatinib in 10 Histologic Subtypes of Sarcoma Using a Bayesian Hierarchical Statistical Model Rashmi Chugh, J. Kyle Wathen, Robert G. Maki, Journal of Clinical Oncology Tumor BiologyTumoral PathologyMalignant DiseaseAdvanced SarcomaMedicine	2009	233
Conservative surgery and adjuvant radiation therapy in the management of adult soft tissue sarcoma of the extremities: Clinical and radiobiological results Arno J. Mundt, A. Awan, Gregory S. Sibley, International Journal of Radiation OncologyBiologyPhysics Surgical OncologyRadiation TherapyRadiobiological ResultsMedicineSoft Tissue Surgery	1995	137
Clinical outcomes and safety with trabectedin therapy in patients with advanced soft tissue sarcomas following failure of prior chemotherapy: results of a worldwide expanded access program study Brian L. Samuels, Sant P. Chawla, Shreyaskumar Patel, Annals of Oncology Surgical OncologyHealth SciencesMedicineCancer ManagementClinical Outcomes	2013	131
Allogeneic hematopoietic transplantation for mantle-cell lymphoma: Molecular remissions and evidence of graft-versus-malignancy Issa F. Khouri, M.-S. Lee, Jorge Romaguera, Annals of Oncology Mantle-cell LymphomaLymphoid NeoplasiaTransplantationMarrow TransplantationMolecular Remissions	1999	129
Phase 2 study of dasatinib in patients with alveolar soft part sarcoma, chondrosarcoma, chordoma, epithelioid sarcoma, or solitary fibrous tumor Scott M. Schuetze, Vanessa Bolejack, Edwin Choy, Cancer	2016	128
SARC009: Phase 2 study of dasatinib in patients with previously treated, high‐grade, advanced sarcoma Scott M. Schuetze, J. Kyle Wathen, David R. Lucas, Cancer	2015	105

Page 1